Search research articles
Contact Us
Filters
Showing results (1-10 of 13) with videos related to
Page
of 2
Sort By:
JIMD Reports
|
February 20, 2020
Use of complementary and alternative medicine in patients with inborn errors of metabolism: A single-center study
Jessica Tao, C Anthony Rupar, Michael R Miller, et al.
Studies in Health Technology and Informatics
|
January 22, 2022
An Evaluation of Pretrained BERT Models for Comparing Semantic Similarity Across Unstructured Clinical Trial Texts
Jessica Patricoski, Kory Kreimeyer, Archana Balan, et al.
Eplasty
|
June 22, 2010
Nitric oxide signaling and neural stem cell differentiation in peripheral nerve regeneration
Jessica Tao Li, Chandra Somasundaram, Ka Bian, et al.
Frontiers in Medicine
|
December 25, 2023
Druggable genomic landscapes of high-grade gliomas
Paola Ghanem, Maria Fatteh, David Olayinka Kamson, et al.
Studies in Health Technology and Informatics
|
August 23, 2024
A Precision Oncology Platform to Support Genotype-Tailored Therapy Selection
Taxiarchis Botsis, Jonathan Spiker, Kory Kreimeyer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 21, 2022
Artificial Intelligence-Assisted Serial Analysis of Clinical Cancer Genomics Data Identifies Changing Treatment Recommendations and Therapeutic Targets
Catherine G Fischer, Aparna Pallavajjala, LiQun Jiang, et al.
Molecular Pharmacology
|
September 13, 2011
Restoring soluble guanylyl cyclase expression and function blocks the aggressive course of glioma
Haifeng Zhu, Jessica Tao Li, Fang Zheng, et al.
JCO Clinical Cancer Informatics
|
April 11, 2023
Precision Oncology Core Data Model to Support Clinical Genomics Decision Making
Taxiarchis Botsis, Joseph C Murray, Paola Ghanem, et al.
Nature Medicine
|
December 19, 2018
RAF inhibitor PLX8394 selectively disrupts BRAF dimers and RAS-independent BRAF-mutant-driven signaling
Zhan Yao, Yijun Gao, Wenjing Su, et al.
Science Translational Medicine
|
August 2, 2013
mTORC1 inhibition is required for sensitivity to PI3K p110α inhibitors in PIK3CA-mutant breast cancer
Moshe Elkabets, Sadhna Vora, Dejan Juric, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 13) with videos related to
Sort By:
Page
of 2
JIMD Reports
|
February 20, 2020
Use of complementary and alternative medicine in patients with inborn errors of metabolism: A single-center study
Jessica Tao, C Anthony Rupar, Michael R Miller, et al.
Studies in Health Technology and Informatics
|
January 22, 2022
An Evaluation of Pretrained BERT Models for Comparing Semantic Similarity Across Unstructured Clinical Trial Texts
Jessica Patricoski, Kory Kreimeyer, Archana Balan, et al.
Eplasty
|
June 22, 2010
Nitric oxide signaling and neural stem cell differentiation in peripheral nerve regeneration
Jessica Tao Li, Chandra Somasundaram, Ka Bian, et al.
Frontiers in Medicine
|
December 25, 2023
Druggable genomic landscapes of high-grade gliomas
Paola Ghanem, Maria Fatteh, David Olayinka Kamson, et al.
Studies in Health Technology and Informatics
|
August 23, 2024
A Precision Oncology Platform to Support Genotype-Tailored Therapy Selection
Taxiarchis Botsis, Jonathan Spiker, Kory Kreimeyer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 21, 2022
Artificial Intelligence-Assisted Serial Analysis of Clinical Cancer Genomics Data Identifies Changing Treatment Recommendations and Therapeutic Targets
Catherine G Fischer, Aparna Pallavajjala, LiQun Jiang, et al.
Molecular Pharmacology
|
September 13, 2011
Restoring soluble guanylyl cyclase expression and function blocks the aggressive course of glioma
Haifeng Zhu, Jessica Tao Li, Fang Zheng, et al.
JCO Clinical Cancer Informatics
|
April 11, 2023
Precision Oncology Core Data Model to Support Clinical Genomics Decision Making
Taxiarchis Botsis, Joseph C Murray, Paola Ghanem, et al.
Nature Medicine
|
December 19, 2018
RAF inhibitor PLX8394 selectively disrupts BRAF dimers and RAS-independent BRAF-mutant-driven signaling
Zhan Yao, Yijun Gao, Wenjing Su, et al.
Science Translational Medicine
|
August 2, 2013
mTORC1 inhibition is required for sensitivity to PI3K p110α inhibitors in PIK3CA-mutant breast cancer
Moshe Elkabets, Sadhna Vora, Dejan Juric, et al.
Page
of 2